News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleNIH-Funded Study Suggests COVID-19 Increases Risk of Pregnancy Complications
February 7, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Pregnant women with COVID-19 appear to be at greater risk for common pregnancy complications — in addition to health risks from the virus — than pregnant women without COVID-19, suggests a study funded by NIH. The study, supported in part by NCATS, included nearly 2,400 pregnant women infected with SARS-CoV-2 and found that those with moderate to severe infection were more likely to have a cesarean delivery, to deliver preterm, to die around the time of birth, or to experience serious illness from hypertensive disorders of pregnancy, postpartum hemorrhage or from infection other than SARS-CoV-2.
International Registry Reveals Risks COVID-19 Poses with Sickle Cell Disease
February 1, 2022 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
NCATS-funded CTSA Program researchers developed a collaborative registry that collects data on COVID-19 illness in people with sickle cell disease.
Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
January 11, 2022 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Findings from NIH’s Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients trial show that convalescent plasma taken from people who had recovered from COVID-19 was not more effective than placebo in delivering clinical improvement 14 days and 28 days after treatment began for people hospitalized with COVID-19.
Can Food Ease Symptoms for People with Bipolar Disorders?
October 1, 2021 - Media Coverage
- Clinical and Translational Science Awards (CTSA) Program
Director’s Message About NCATS’ Role in the APP
July 30, 2021 - NCATS News
- Antiviral Program for Pandemics (APP)
The NCATS Director discusses NCATS' support of the APP, a federal, academic and private sector collaborative effort created to accelerate antiviral development and prevent future pandemics.
Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms
April 19, 2021 - NCATS News
- COVID-19
- Clinical and Translational Science Awards (CTSA) Program
As part of NIH’s ACTIV partnership, NCATS’ CTSA Program will play a key role in a large clinical trial for mild to moderate COVID-19 to test several existing drugs to see if they provide safe, effective symptom relief and prevent hospitalization.